O Closs
Impact in
- Microbiology top 0.5%
- Bacterial Infections and Vaccines
- Infectious Diseases top 1%
- Leprosy Research and Treatment
- Tuberculosis Research and Epidemiology
Papers in
- Epidemiology 57
- Mycobacterium research and diagnosis 47
- Pneumonia and Respiratory Infections 6
-
- Leprosy Research and Treatment 40
- Tuberculosis Research and Epidemiology 18
- Co-authors
- M Harboe (25 shared papers)N. H. AXELSEN (5 shared papers)G Kronvall (6 shared papers)Olav A. Haugen (6 shared papers)Hanne Nøkleby (5 shared papers)G Bjune (5 shared papers)L O Frøholm (4 shared papers)Einar Rosenqvist (4 shared papers)
In The Last Decade
O Closs
87 papers receiving 1.9k citations
O Closs's Hit Papers
Peers
Comparison fields: 5 of 94
- Microbiology 714
- Infectious Diseases 1.0k
- Epidemiology 1.5k
- Immunology 412
- Pharmacology 167
Countries citing papers authored by O Closs
This map shows the geographic impact of O Closs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O Closs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O Closs more than expected).
Fields of papers citing papers by O Closs
This network shows the impact of papers produced by O Closs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O Closs. The network helps show where O Closs may publish in the future.
Co-authors
The 25 scholars most cited alongside O Closs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway Hit paper breakdown → | 1991 | 606 |
| 2 | 1980 | 173 | |
| 3 | 1979 | 86 | |
| 4 | 1977 | 79 | |
| 5 | 1975 | 75 | |
| 6 | 1987 | 68 | |
| 7 | 1988 | 55 | |
| 8 | 1975 | 53 | |
| 9 | 1979 | 48 | |
| 10 | 1978 | 47 | |
| 11 | 1979 | 41 | |
| 12 | 1974 | 41 | |
| 13 | 1977 | 40 | |
| 14 | 1974 | 36 | |
| 15 | Results of an efficacy trial with an outer membrane vesicle vaccine against systemic serogroup B meningococcal disease in Norway. | 1991 | 36 |
| 16 | 1975 | 32 | |
| 17 | Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine. | 1998 | 31 |
| 18 | 1977 | 28 | |
| 19 | 1975 | 26 | |
| 20 | 1971 | 26 |
About O Closs
O Closs is a scholar working on Epidemiology, Infectious Diseases, Molecular Biology, Surgery and Immunology, having authored 90 papers that have together received 2.3k indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (47 papers), Leprosy Research and Treatment (40 papers), Tuberculosis Research and Epidemiology (18 papers), Infectious Diseases and Tuberculosis (12 papers), Connexins and lens biology (7 papers), Bacterial Infections and Vaccines (7 papers), Pneumonia and Respiratory Infections (6 papers) and Pharmacological Effects of Natural Compounds (6 papers). The work is most often cited by research in Microbiology (714 citations), Infectious Diseases (1.0k citations), Epidemiology (1.5k citations), Immunology (412 citations) and Pharmacology (167 citations). O Closs has collaborated with scholars based in Norway, Ethiopia and Denmark. Frequent co-authors include M Harboe, N. H. AXELSEN, G Kronvall, Olav A. Haugen, Hanne Nøkleby, G Bjune, L O Frøholm, Einar Rosenqvist, E. Arne Høiby and Martinus Løvik. Their work appears in journals such as Scandinavian Journal of Immunology, Infection and Immunity, Experimental Eye Research, Leprosy Review and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.